1. IRBNMU - Репозитарій Національного медичного університету імені О.О.Богомольця

Перегляд зібрання за групою - Автори Stepanova, N.

Перейти до: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я І Ї Є
або ж введіть декілька перших літер:  
Результати 23 до 42 із 44 < назад   далі >
Дата випускуНазваАвтор(и)
2022Oxalate Balance in Peritoneal Dialysis Patients: A Potential Role of Dialysis-related PeritonitisStepanova, N.; Korol, L.; Lebid, L.; Snisar, L.; Savchenko, S.
2020Oxalate-degrading activity in fecal microbiota associated with blood lipid profile in dialysis patientsStepanova, N.; Tolstanova, G.; Akulenko, I.; Savchenko, O.; Lebid, L.; Skovorodka, M.; Kolesnyk, M.
2019Oxidative status in hemodialysis patients with erythropoietin hyporesponsiveness anemiaKorol, L.; Stepanova, N.; Novakisksiy, V.; Shifris, I.; Migal, L.
2019Oxidative stress in peritoneal dialysis patients: association with the dialysis adequacy and technique survivalStepanova, N.; Korol, L.; Burdeyna, O.
2019Plant Extracts in Hyperoxaluria Treatment: A Review of Experimental and Clinical ResearchStepanova, N.
2021Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot studyStepanova, N.; Driianska, V.; Korol, L.; Snisar, L.; Lebed, L.
2020Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot studyStepanova, N.; Driianska, V.; Korol, L.; Snisar, L.; Lebed, L.
2021Plasma oxalic acid as a significant risk factor for cardiovascular disease in end-stage renal disease patientsStepanova, N.; Snaisar, L.; Lebid, L.
2020Prevention, diagnosis and management of influenza in CKD patients: Adapted clinical guidelines of the Ukrainian Association of Nephrologists and Kidney Transplant SpecialistsKolesnyk, M.; Stepanova, N.; Snisar, L.; Liksunova, L.; Lebid, L.; Velychko, M.
2020Regulation of oxalate homeostasis by oxalate-degrading activity in fecal microbiota in dialysis patientsStepanova, N.; Tolstanova, G.; Akulenko, I.; Korol, L.; Savchenko, O.; Snisar, L.; Kolesnyk, M.
2021Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion ArticleStepanova, N.
2020Serum paraoxonase 1 arylesterase activity as an antioxidant marker in dialysis patientsKorol, L.; Stepanova, N.; Vasylchenko, V.
2022Serum total indoxyl sulfate is associated with intraperitoneal inflammation and high peritonitis episodes in peritoneal dialysis patientsStepanova, N.; Korol, L.; Driianska, V.; Snisar, L.; Lebid, L.; Kompaniets, O.
2022Synbiotic supplementation and oxalate homeostasis in rats: focus on microbiota oxalate‑degrading activityStepanova, N.; Akulenko, I.; Serhiichuk, T.; Dovbynchuk, T.; Savchenko, S.; Tolstanova, G.
2021The association between nephrotic-range proteinuria and oxalate metabolism violation in patients with primary glomerulonephritisStepanova, N.; Snisar, L.; Lebid, L.; Savchenko, S.
2021The long-term effects of acute kidney injury on intestinal oxalate-degrading bacteria in rats. Nephrol Dial TransplantStepanova, N.; Tolstanova, G.; Nepomnyashchii, V.; Akulenko, I.; Savchenko, S.; Kolesnyk, M.
2019-05The predictive value of hyperuricemia in residual diuresis decline in peritoneal dialysis patientsStepanova, N.; Surzhko, L.; Lebid, L.; Snisar, L.; Kolesnyk, M.
2020The predictive value of serum uric acid in primary glomerulonephritis patients: a 5-years renal prognosisKolesnyk, M.; Stepanova, N.; Snisar, L.; Lebid, L.
2018The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patientsStepanova, N.; Korol, L.; Novakivskyy, V.; Kolesnyk, M.
2019-06Uric acid induces intraperitoneal inflammation in peritoneal dialysis patients.Stepanova, N.; Burdeyna, O.; Driianska, V.; Snisar, L.
Результати 23 до 42 із 44 < назад   далі >